MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay
NCT ID: NCT04659746
Last Updated: 2022-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
138 participants
INTERVENTIONAL
2020-12-09
2021-12-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This mHealth solution is built upon the Adhera platform, which has already been validated in other therapeutic areas such as smoking cessation.
MejoraCare is expected to raise awareness, educate and empower chronic patients, promoting behavioral changes towards adhering to healthier lifestyles thus reducing the risk of COVID-19 infection while providing emotional regulation support aiming at improving their mental health, quality of life, and emotional well-being.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology
NCT04756869
Determine Return on Investment in Heart Failure Remote Monitoring Program
NCT02475577
Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers of Adults Discharged From the Emergency Department.
NCT07348081
Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
NCT01808053
Identifying Mental Health Distress in EM Physicians
NCT05606887
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This mHealth solution is built upon the Adhera platform, which has already been validated in other therapeutic areas such as smoking cessation.
Its objective is two-fold: on the one hand, MejoraCare will provide the target population with an educational resource to improve their self-efficacy and knowledge about the disease and, on the other hand, to provide them with tools for the regulation of stress, anxiety and negative emotions generated in this high-risk population due to the COVID-19 outbreak situation.
MejoraCare is expected to raise awareness, educate and empower chronic patients, promoting behavioral changes towards adhering to healthier lifestyles thus reducing the risk of COVID-19 infection, while providing emotional regulation support aiming at improving their mental health, quality of life, and emotional well-being.
Personalized health education embedded into MejoraCare app covers the following topics:
* Prevention of COVID-19
* Reinforcement of self-management behaviors for chronic conditions (e.g., physical activity).
* Modules for improving resilience and coping skills related to stress and negative emotions related to the COVID-19 outbreak (e.g., isolation at home).
For health care providers, MejoraCare dashboard provides the following functionalities:
* Segmentation, monitoring, and follow-up of potential positive cases of COVID19 patients and people at special risk
* Support to patients undergoing quarantine at home recovery phase, including remote monitoring of symptoms and a means to contact them in the cases that are deemed necessary by the healthcare professionals.
The specific objectives of MejoraCare-Paraguay are:
1. To analyze the impact of the MejoraCare mHealth solution in terms of mental health, quality of life, and emotional well-being in chronic patients at risk of COVID-19 infection.
2. To analyze the acceptance of the technology by patients and professionals.
This study expects to demonstrate the benefits that an mHealth intervention may have on supporting mental health, quality of life, and emotional well-being for vulnerable patients during the COVID-19 outbreak.
The "info-demia" of constant news about the virus, along with the restrictive/lockdown measures that are being enforced by the governments to reduce the pandemic progression pose a great challenge for the emotional stress for people in general, and with a higher impact on a vulnerable population, especially for those living with chronic conditions that seem to worsen the prognostic in case of infection. Besides, as the pandemic continues its spread, health services are being challenged due to the lack of resources to cope with such a high demand for potential positive cases. In some cases, this affects the quality of care of chronic patients, who also refrain from attending their routine appointments due to the fear of infection. Therefore, reinforcement and behavioral guidance are needed to allow people living with chronic conditions to know and understand which are the measures they need to take to prevent the infection, or how to act in the event that they are infected. Besides, it is necessary to provide this population with tools to support the prevention of psychological and emotional problems that can worsen their health status and, therefore, their quality of life.
mHealth solutions rely on a technology (smartphones) which already has a high level of penetration in the population, makes their widespread highly scalable, and can be released with relatively low costs. If developed under strong quality and safety requirements, they can be a perfect fit for building public health strategies on top of them. On the other hand, the lack of specific digital solutions to educate and empower chronic patients in disease prevention techniques for COVID-19 and other infectious diseases with a relatively high mortality rate among the vulnerable population like the seasonal flu puts them in an even more risky situation to get infected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants allocated to the control group will receive the routine care and follow-up for chronic patients in Pandemic situation at Hospital Regional de Encarnación (Encarnación, Paraguay), according to epidemiological surveillance and preventive isolation management protocol released by the Ministry of Health of Paraguay (URL: https://www.mspbs.gov.py/dependencias/portal/adjunto/c1c79a-ProtocoloVigilanciaEpidemiolgica.pdf)
No interventions assigned to this group
Intervention
Participants allocated to the intervention group will follow the same routine care as the control group. Additionally, they will receive access to the MejoraCare app.
The MejoraCare app delivers the following functionalities:
* Remote symptoms monitoring through an electronic Patient Reported Outcome (ePRO)
* Patient empowerment through personalized educational resources promoting healthy lifestyles
MejoraCare
mHealth solution to support remote monitoring of symptoms and patient empowerment through education.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MejoraCare
mHealth solution to support remote monitoring of symptoms and patient empowerment through education.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients suffering from, at least, one chronic disease.
* Patients owning an Android smartphone and internet connection
* Patients with a minimum level of digital literacy (being able to send text messages)
* Patients able to read and understand Spanish
* Signs the informed consent
Exclusion Criteria
* Withdraws the consent to participate in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Adhera Health, Inc.
INDUSTRY
University of Valencia
OTHER
Universidad Autónoma de Encarnación
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rosa María Baños, PhD
Role: PRINCIPAL_INVESTIGATOR
Universitat de València-Estudi General
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Regional de Encarnación
Encarnación, Itapúa, Paraguay
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Escriva-Martinez T, Vara MD, Czeraniuk N, Denis M, Nunez-Benjumea FJ, Fernandez-Luque L, Jimenez-Diaz A, Traver V, Llull JJ, Martinez-Millana A, Garces-Ferrer J, Miragall M, Herrero R, Enriquez A, Schaefer V, Cervera-Torres S, Villasanti C, Cabral CV, Fernandez I, Banos RM. mHealth intervention to improve quality of life in patients with chronic diseases during the COVID-19 crisis in Paraguay: A study protocol for a randomized controlled trial. PLoS One. 2022 Nov 8;17(11):e0273290. doi: 10.1371/journal.pone.0273290. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PINV 20-9
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.